Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
06/2005
06/15/2005CN1206218C Aryl phenyl substituted cyclic ketoenols
06/14/2005US6906202 Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a method for effective purification of racemic lasofoxifene
06/14/2005US6906201 Utilizing metal catalyst; one step; low cost
06/14/2005US6906200 Production of N-vinyl pyrrolidone
06/14/2005US6906199 Process for preparing distamycin derivatives
06/14/2005US6906198 Protease inhibitors; viricides
06/14/2005US6906192 Processes for the preparation of acid derivatives useful as serine protease inhibitors
06/14/2005US6906105 Administering to a cancer patient an effective amount of chalcone or its derivaties to treat the tumor/cancer
06/14/2005US6906103 Compounds possessing antibacterial, antifungal or antitumor activity
06/14/2005US6906097 A 7-(5-oxo-pyrrolidin-1-yl)-heptanoic acid or ester derivatives for therapeutic treatment of eye hypertension or glaucoma
06/14/2005US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase
06/14/2005US6906079 Method and reagents for N-alkylating ureides
06/14/2005US6906072 Central nervous system disorders
06/14/2005US6906066 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6905804 Charge transport material comprising a fluorenone hydrazone having a) least two fluorenone alkylsulfonylphenylhydrazone groups, b) at least two fluorenone pyrrolylhydrazone groups, c) at least two fluorenone benzotriazolylhydrazone groups, d)
06/14/2005US6905739 Optically active materials
06/14/2005US6905297 Locking nut, bolt and clip systems and assemblies
06/14/2005CA2163122C Positive inotropic and lusitropic pyrroloquinolinone derivatives
06/14/2005CA2155952C Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
06/14/2005CA2150229C Nitric esters having a pharmacological activity and process for their preparation
06/09/2005WO2005052016A2 Bottom antireflective coatings
06/09/2005WO2005051914A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
06/09/2005WO2005051907A1 Process for the production of lactams
06/09/2005WO2005051895A1 Organic compounds
06/09/2005WO2005051878A1 Aldehyde carrying zeolite
06/09/2005WO2004052845A8 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
06/09/2005US20050124683 Viricides; immunomoderators
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity
06/09/2005US20050124654 Compounds and methods of use
06/09/2005US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
06/09/2005US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
06/09/2005US20050124497 Pesticide, 5-tert-butyl-2-{4-[5-(2,6-difluorophenyl)-3,4-dihydro-2H-pyrrol-2-yl]phenyl}-1,3-benzoxazole; chemical intermediates, N-(5-tert-butyl-2-hydroxyphenyl)-4-[5-(2,6-difluorophenyl)-3,4-dihydro-2H-pyrrol-2-yl]benzamide; applying on plants, animals
06/09/2005US20050124001 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
06/09/2005US20050123849 Electrophotographic organophotoreceptors with novel charge transport materials
06/09/2005US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions
06/09/2005US20050120913 reacting oxo esters with nitriles in the presennce of hydrogen, hydrogenation catalysts and optionally catalysts supports, to form heterocyclic amides, then mixing the products with surfactants, alcohols, hydroxy ethers and/or oxy amines, to form mixtures used as cleaning compounds
06/09/2005US20050120912 Catalyzing the hydrogen reduction in the presence of metal catalyst and catalyst support; cyclization, amidation; low cost chemical intermediates for producing solvent, electronics, cleaners, inks, gasolines and oil additives, agricultural products, detergent, dispersant, printing inks
06/09/2005DE10351647A1 2-Halogen-6-alkyl-phenyl substituierte Tetramsäure-Derivate 2-halo-6-alkyl-phenyl substituted tetramic acid derivatives
06/09/2005CA2546142A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
06/08/2005EP1538159A1 Substituted N-benzyl-lactam derivatives as melanocortin-4 receptor agonists
06/08/2005EP1538150A1 Novel pleuromutilin derivatives
06/08/2005EP1538138A1 Substituted benzanilide compound and pest control agent
06/08/2005EP1537870A2 Methods and compositions for treating cancer
06/08/2005EP1537077A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
06/08/2005EP1537076A1 Novel vinyl carboxylic acid derivatives and their therapeutical use
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1537068A1 Materials and methods for treating hypercholesterolemia
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP1299774A4 Perfluoroalkylsulfonic acid compounds for photoresists
06/08/2005EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/08/2005EP1068182B1 Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one
06/08/2005EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
06/08/2005CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes
06/08/2005CN1625548A Purified LASOFOXIFENE and a method for purification of racemic LASOFOXIFENE by recrystallization
06/08/2005CN1205211C Pleuromutilin derivatives as antimicrobials
06/08/2005CN1205187C New amidino derivatives and their use as thrombin inhibitors
06/08/2005CN1205186C ACE inhibitor nitric salts
06/08/2005CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
06/08/2005CN1205183C New amidino derivatives and their use as thrombin inhibitors
06/08/2005CN1205180C 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
06/08/2005CN1205179C (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
06/07/2005US6903222 Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-cycloalkyl-2-pyrrolidone by reductive amination of levulinic acid with aryl amines
06/07/2005US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
06/07/2005US6903130 (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide stereoisomer for the treatment of bipolar disorders
06/07/2005US6903129 D-proline prodrugs
06/07/2005US6903114 Carbocyclic alcohols such as 1,6-dinitronaphthalene-2,3-diol, used as catechol-O-methyltransferase inhibitors, for prophylaxis of Parkinson's disease
06/07/2005CA2244139C Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
06/02/2005WO2005049603A1 Pyrrol derivatives
06/02/2005WO2005049594A1 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049593A2 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049590A2 N-sulfonylaminocarbonyl containing compounds
06/02/2005WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
06/02/2005WO2005049565A1 N-sulfonyldicarboximide containing tethering compounds
06/02/2005WO2005049564A1 Amide derivatives and methods of their use
06/02/2005WO2005049532A2 A process for purification
06/02/2005WO2005049023A1 Glyt1 transporter inhibitors
06/02/2005WO2005048922A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
06/02/2005WO2005048710A1 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides
06/02/2005US20050119494 Catalytically hydrogenating C4-dicarboxylic acids and/or derivatives thereof in the gas phase in the presence of copper catalysts and reacting gama-butyrolactone with ammonia or primary amines to give pyrrolidones
06/02/2005US20050119493 Process for the preparation of amorphous atorvastin calcium salt (2:1)
06/02/2005US20050119416 Ring-opening or closing metathesis reaction of olefin; reduction of carbonyl compound, catalysis, complexing; cyclization, reduction
06/02/2005US20050119332 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases)
06/02/2005US20050119329 Tetronic and tetramic acids
06/02/2005US20050119315 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators; potassium channel moderators; prevention fibrillation
06/02/2005US20050119256 Aromatic amino acid derivates and medicinal compositions
06/02/2005US20050119252 Ligands of melanocortin receptors and compositions and methods related thereto
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119227 Cyclic amine bace-1 inhibitors having a benzamide substituent
06/02/2005US20050119130 Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses
06/02/2005DE10354060A1 Pyrrolderivate Pyrrole
06/02/2005CA2546817A1 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1535908A1 N-acyl-N'-benzyl-alkylendiamino drivatives
06/01/2005EP1535907A1 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
06/01/2005EP1535906A1 Nitrogen-containing compounds
06/01/2005EP1535905A1 Process for the preparation of paraphenylendiamines comprising pyrrolidines substituted by nitrogenradicals and their intermediates
06/01/2005EP1535904A2 Process for the preparation of optically active 1-(4-nitrophenyl)-3-pyrrolidinole derivatives, paraphenylenediaines comprising chiral pyrrolidinyl groups
06/01/2005EP1535613A2 Polymorphic form of atorvastatin calcium